Item 5.07 Submission of Matters to a Vote of Security Holders

Our Annual Meeting of Shareholders was held April 27, 2023. At that meeting, shareholders took the following actions with respect to the proposals described in our 2023 Proxy Statement:

1. The following directors were elected:



                          For            Withheld        Broker Non-Votes
Analisa M. Allen        247,681,859         479,725              14,878,284
Daniel A. Arrigoni      244,795,524       3,366,060              14,878,284
C. Edward Chaplin       246,715,541       1,446,043              14,878,284
Curt S. Culver          243,725,292       4,436,292              14,878,284
Jay C. Hartzell         247,353,290         808,294              14,878,284
Timothy A. Holt         241,829,046       6,332,538              14,878,284
Jodeen A. Kozlak        243,589,196       4,572,388              14,878,284
Michael E. Lehman       235,922,475      12,239,109              14,878,284
Teresita M. Lowman      247,297,141         864,443              14,878,284
Timothy J. Mattke       246,201,525       1,960,059              14,878,284
Sheryl L. Sculley       247,295,230         866,354              14,878,284
Mark M. Zandi           245,717,145       2,444,439              14,878,284




2. The compensation of our named executive officers for 2022 was approved, on an advisory basis, by the following vote:



     For            Against        Abstain        Broker Non-Votes
 243,631,394       4,242,357       287,833           14,878,284



3. The shareholders indicated, on an advisory basis, the preferred frequency of advisory votes on the compensation of our named executive officers to be one year by the following vote:



    1 Year          2 Years        3 Years         Abstain        Broker Non-Votes
 235,222,819        293,869       12,461,212       183,684               0




4. The ratification of the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the year ending December 31, 2023 was approved by the following vote:




     For            Against        Abstain
 254,893,895       8,027,994       117,979





--------------------------------------------------------------------------------

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits. The following exhibits are being filed herewith:



         Exhibit No.          Description

         104                  Cover Page Interactive Data File (the cover page XBRL tags are
                              embedded within the Inline XBRL document).


--------------------------------------------------------------------------------

© Edgar Online, source Glimpses